IVDR Support for In Vitro Diagnostic Manufacturers
We support you navigating In-Vitro Diagnostic Regulation (EU) 2017/746 with a practical, evidence-driven roadmap, from classification and technical documentation to performance evaluation and post-market follow-up.
Madrid-based CRO support for EU market access and evidence generation.
Build an IVDR-ready dossier that stands up to Notified Body expectations
IVDR requires stronger evidence, tighter traceability, and a structured approach to performance evaluation and post-market surveillance. We help you plan, generate, and compile the evidence needed to support conformity assessment and lifecycle compliance.
IVDR Services
-
Device classification support and rationale
Conformity assessment planning and submission roadmap
-
Gap assessment against IVDR requirements
Transition plan with priorities, timelines, and resource needs
-
Document structure and medical writing
Consistency checks across intended purpose, claims, risk, and evidence
-
Performance Evaluation Plan and Report (PEP/PER) development
Evidence mapping (scientific validity + analytical + clinical performance)
-
Clinical performance study execution and oversight
Analytical performance study
-
QMS alignment to IVDR needs (process integration, readiness)
Risk management file support aligned with ISO 14971 approaches
-
PMS planning and reporting
PMPF system setup and periodic reports (PSUR; SSP/SSP for IVDR)
-
Notified Body engagement strategy and response support
EUDAMED operator/device registration support where applicable
Typical deliverables
IVDR classification memo + conformity assessment plan
IVDD→IVDR transition plan (legacy devices)
Annex II/III Technical Documentation structure and content support
PEP + PER (performance evaluation plan/report)
PMS plan + PMPF plan/reports; PSUR/SSP
Notified Body interaction pack (readiness review + responses)
FAQs
-
Many IVDs require NB involvement under IVDR; only limited low-risk cases can be self-certified.
-
MDR governs medical devices; IVDR governs in vitro diagnostics and has specific performance evaluation and post-market performance requirements.
-
A structured report compiling scientific validity and analytical/clinical performance evidence to support IVDR compliance and conformity assessment.
-
Yes, gap assessment, reclassification considerations, and a transition plan to close documentation and evidence gaps.
-
Yes—planning and reporting support to maintain compliance across the device lifecycle.
Need an IVDR roadmap you can actually execute?
Share your device summary and current status. We will propose a practical next-step plan focused on regulatory readiness and evidence generation.